These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
24426 results:

  • 1. Local Anesthetic Bupivacaine Inhibits Melanoma Proliferation and Metastasis by Targeting PAPSS2.
    Guan E; Zhang J; Zhou J; Liu Y; Xu N
    Discov Med; 2024 Jul; 36(186):1499-1512. PubMed ID: 39054720
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
    Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
    Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].
    Li H; Li G; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1361-1369. PubMed ID: 39051082
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials.
    Zhan Y; Cheng X; Mei P; Tan S; Feng W; Jiang H
    BMC Cancer; 2024 Jul; 24(1):893. PubMed ID: 39048944
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
    Karthaus M; Heinemann V; Riera-Knorrenschild J; Kretzschmar A; Welslau M; Kaiser U; Pelz H; Ettrich TJ; Held S; Kehmann L; Hess J; Reisländer T; Weiss L;
    BMC Cancer; 2024 Jul; 24(1):887. PubMed ID: 39044160
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparing cranial-caudal-medial and medial-lateral approaches for laparoscopic right hemicolectomy: a propensity score-matched analysis.
    Wang J; Zhou J; Cheng Y; Zhao S; Li R; Zhang C; Fu Y; Sun L; Ren J; Wang D
    World J Surg Oncol; 2024 Jul; 22(1):187. PubMed ID: 39039538
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study.
    Sue-Chue-Lam C; Brezden-Masley C; Sutradhar R; Yu AYX; Baxter NN
    BMC Cancer; 2024 Jul; 24(1):878. PubMed ID: 39039514
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review.
    Chung KC; Muthutantri A; Goldsmith GG; Watts MR; Brown AE; Patrick DL
    BMC Cancer; 2024 Jul; 24(1):884. PubMed ID: 39039461
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Longitudinal impact of screening colonoscopy on greenhouse gas emissions.
    Yusuf H; Gupta V; Osaghae I; Kumar A
    PLoS One; 2024; 19(7):e0307133. PubMed ID: 39028703
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Response of various histological types of locally advanced rectal cancer to neoadjuvant multimodality therapy.
    Nadeem MS; Ali U; Khan A; Wajid I; Riaz O; Azeem MT
    J Pak Med Assoc; 2024 Jul; 74(7):1240-1244. PubMed ID: 39028047
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review).
    Cameselle-García S; Abdulkader-Nallib I; Sánchez-Ares M; Cameselle-Teijeiro JM
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39027989
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of hospitalization expenses and influencing factors for elderly cancer patients in a tertiary hospital in Dalian, China: a five‑year retrospective study.
    Zhang L; Zhuang X; Yang X; Xu F; Wang N; Guo Z; Chen J; Ding D
    BMC Cancer; 2024 Jul; 24(1):864. PubMed ID: 39026195
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of electroacupuncture of "Zusanli" (ST36) combined with capeOX on apoptosis and ferroptosis in nude mice with colorectal cancer.
    Li ZL; Zeng WJ; Li GH; Zhang JT; Li ZC; Wang SY; Qiu FH; Li SW
    Zhen Ci Yan Jiu; 2024 Jul; 49(7):678-685. PubMed ID: 39020485
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A randomized controlled trial of a self-led, virtual reality-based cognitive behavioral therapy on sick role adaptation in colorectal cancer patients: study protocol.
    Li X; Wu X; Chen C; Chao H; Xie J; Du Q; Zhang M
    BMC Cancer; 2024 Jul; 24(1):847. PubMed ID: 39020293
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Factors Associated With Continuous Use of a cancer Education Metaverse Platform: Mixed Methods Study.
    Kim S; Jung T; Sohn DK; Suh M; Chang YJ
    J Med Internet Res; 2024 Jul; 26():e57762. PubMed ID: 39008834
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Implementing a no-drain policy for extraperitoneal colorectal anastomosis in a real-life setting: analysis of outcomes and surgeons' adherence.
    Crippa J; Luberto A; Magistro C; Carvello M; Carnevali P; Maroli A; Ferrari GC; Spinelli A
    Int J Colorectal Dis; 2024 Jul; 39(1):109. PubMed ID: 39008120
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of 6-Anilino Imidazo[4,5-
    Hong CR; Liew LP; Wong WW; Dickson BD; Cheng G; Shome A; Airey R; Jaiswal J; Lipert B; Jamieson SMF; Wilson WR; Hay MP
    J Med Chem; 2024 Jul; 67(14):12366-12385. PubMed ID: 39007759
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Current status of palliative care for patients with unresectable metastatic colorectal cancer in China: a questionnaire-based survey].
    Wang F; Chen DL; Wang ZX; He Y; Li J; Zhang SZ; Chen G; Xu JM; Yuan XL; Zhang YQ; Xu RH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jul; 27(7):718-725. PubMed ID: 39004987
    [No Abstract]    [Full Text] [Related]  

  • 19. Outcomes Among Racial and Ethnic Minority Patients With Advanced cancers in Phase 1 Trials: A Meta-Analysis.
    Goel S; Negassa A; Ghalib MH; Chaudhary I; Desai K; Shah U; Swami U; Cohen B; Maitra R; Mani S
    JAMA Netw Open; 2024 Jul; 7(7):e2421485. PubMed ID: 38990570
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US.
    Paly VF; Dasari A; Hubbard J; Bekaii-Saab T; Padukkavidana T; Hernandez L
    J Comp Eff Res; 2024 Aug; 13(8):e240084. PubMed ID: 38976346
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 1222.